Chemesis International Inc. announced that it is expecting strong 2nd quarter sales from its six operational dispensaries in California & Puerto Rico. GSRX announced it has daily sales for the first three weeks of the 2nd quarter, which are approximately 27% higher than its average daily sales in the 1st quarter. With such strong sales, GSRX anticipates revenues of approximately $3.3 million to $3.5 million for the 2nd quarter 2019.